Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2018 Mar 22

PMID 29561796

Citations 79

Authors

Beatrice Xuan Ho

Nicole Min Qian Pek

Boon-Seng Soh

Affiliations

Soon will be listed here.

Abstract

The rising interest in human induced pluripotent stem cell (hiPSC)-derived organoid culture has stemmed from the manipulation of various combinations of directed multi-lineage differentiation and morphogenetic processes that mimic organogenesis. Organoids are three-dimensional (3D) structures that are comprised of multiple cell types, self-organized to recapitulate embryonic and tissue development in vitro. This model has been shown to be superior to conventional two-dimensional (2D) cell culture methods in mirroring functionality, architecture, and geometric features of tissues seen in vivo. This review serves to highlight recent advances in the 3D organoid technology for use in modeling complex hereditary diseases, cancer, host-microbe interactions, and possible use in translational and personalized medicine where organoid cultures were used to uncover diagnostic biomarkers for early disease detection via high throughput pharmaceutical screening. In addition, this review also aims to discuss the advantages and shortcomings of utilizing organoids in disease modeling. In summary, studying human diseases using hiPSC-derived organoids may better illustrate the processes involved due to similarities in the architecture and microenvironment present in an organoid, which also allows drug responses to be properly recapitulated in vitro.

Citing Articles

3D bioprinting technology innovation in female reproductive system.

Chen S, Wang T, Chen J, Sui M, Wang L, Zhao X Mater Today Bio. 2025; 31:101551.

PMID: 40026632 PMC: 11870202. DOI: 10.1016/j.mtbio.2025.101551.

Open Microfluidic Cell Culture in Hydrogels Enabled by 3D-Printed Molds.

OBrien M, Spirrison A, Abdul Halim M, Li Y, Neild A, Gemrich C Bioengineering (Basel). 2025; 12(2).

PMID: 40001622 PMC: 11851523. DOI: 10.3390/bioengineering12020102.

From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care.

Tanaka M Biomedicines. 2025; 13(1).

PMID: 39857751 PMC: 11761901. DOI: 10.3390/biomedicines13010167.

Breaking the mold: 3D cell cultures reshaping the future of cancer research.

Cordeiro S, Oliveira B, Valente R, Ferreira D, Luz A, Baptista P Front Cell Dev Biol. 2024; 12:1507388.

PMID: 39659521 PMC: 11628512. DOI: 10.3389/fcell.2024.1507388.

Modeling corticotroph deficiency with pituitary organoids supports the functional role of in human pituitary differentiation.

Mac T, Fauquier T, Jullien N, Romanet P, Etchevers H, Barlier A Elife. 2024; 12.

PMID: 39607428 PMC: 11604219. DOI: 10.7554/eLife.90875.

References

Huch M, Knoblich J, Lutolf M, Martinez-Arias A . The hope and the hype of organoid research. Development. 2017; 144(6):938-941. DOI: 10.1242/dev.150201. View

Nantasanti S, de Bruin A, Rothuizen J, Penning L, Schotanus B . Concise Review: Organoids Are a Powerful Tool for the Study of Liver Disease and Personalized Treatment Design in Humans and Animals. Stem Cells Transl Med. 2016; 5(3):325-30. PMC: 4807664. DOI: 10.5966/sctm.2015-0152. View

Hayashi Y, Furue M . Biological Effects of Culture Substrates on Human Pluripotent Stem Cells. Stem Cells Int. 2016; 2016:5380560. PMC: 5021488. DOI: 10.1155/2016/5380560. View

Yin X, Mead B, Safaee H, Langer R, Karp J, Levy O . Engineering Stem Cell Organoids. Cell Stem Cell. 2016; 18(1):25-38. PMC: 4728053. DOI: 10.1016/j.stem.2015.12.005. View

Ito R, Takahashi T, Katano I, Ito M . Current advances in humanized mouse models. Cell Mol Immunol. 2012; 9(3):208-14. PMC: 4012844. DOI: 10.1038/cmi.2012.2. View

Li R, Sun L, Fang A, Li P, Wu Q, Wang X . Recapitulating cortical development with organoid culture in vitro and modeling abnormal spindle-like (ASPM related primary) microcephaly disease. Protein Cell. 2017; 8(11):823-833. PMC: 5676597. DOI: 10.1007/s13238-017-0479-2. View

Yamanaka S . Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2008; 1(1):39-49. DOI: 10.1016/j.stem.2007.05.012. View

Lee C, Bendriem R, Wu W, Shen R . 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders. J Biomed Sci. 2017; 24(1):59. PMC: 5563385. DOI: 10.1186/s12929-017-0362-8. View

Shultz L, Brehm M, Garcia-Martinez J, Greiner D . Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012; 12(11):786-98. PMC: 3749872. DOI: 10.1038/nri3311. View

10.

Raja W, Mungenast A, Lin Y, Ko T, Abdurrob F, Seo J . Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. PLoS One. 2016; 11(9):e0161969. PMC: 5021368. DOI: 10.1371/journal.pone.0161969. View

11.

Courchesne E, Mouton P, Calhoun M, Semendeferi K, Ahrens-Barbeau C, Hallet M . Neuron number and size in prefrontal cortex of children with autism. JAMA. 2011; 306(18):2001-10. DOI: 10.1001/jama.2011.1638. View

12.

Saha K, Mei Y, Reisterer C, Pyzocha N, Yang J, Muffat J . Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions. Proc Natl Acad Sci U S A. 2011; 108(46):18714-9. PMC: 3219112. DOI: 10.1073/pnas.1114854108. View

13.

Spence J, Mayhew C, Rankin S, Kuhar M, Vallance J, Tolle K . Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2010; 470(7332):105-9. PMC: 3033971. DOI: 10.1038/nature09691. View

14.

Lawrenson K, Notaridou M, Lee N, Benjamin E, Jacobs I, Jones C . In vitro three-dimensional modeling of fallopian tube secretory epithelial cells. BMC Cell Biol. 2013; 14:43. PMC: 3849984. DOI: 10.1186/1471-2121-14-43. View

15.

van de Wetering M, Francies H, Francis J, Bounova G, Iorio F, Pronk A . Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015; 161(4):933-45. PMC: 6428276. DOI: 10.1016/j.cell.2015.03.053. View

16.

Dye B, Hill D, Ferguson M, Tsai Y, Nagy M, Dyal R . In vitro generation of human pluripotent stem cell derived lung organoids. Elife. 2015; 4. PMC: 4370217. DOI: 10.7554/eLife.05098. View

17.

Magdeldin T, Lopez-Davila V, Pape J, Cameron G, Emberton M, Loizidou M . Engineering a vascularised 3D in vitro model of cancer progression. Sci Rep. 2017; 7:44045. PMC: 5343474. DOI: 10.1038/srep44045. View

18.

Bassett A . Editing the genome of hiPSC with CRISPR/Cas9: disease models. Mamm Genome. 2017; 28(7-8):348-364. PMC: 5569153. DOI: 10.1007/s00335-017-9684-9. View

19.

Monzel A, Smits L, Hemmer K, Hachi S, Lucumi Moreno E, van Wuellen T . Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells. Stem Cell Reports. 2017; 8(5):1144-1154. PMC: 5425618. DOI: 10.1016/j.stemcr.2017.03.010. View

20.

Duval K, Grover H, Han L, Mou Y, Pegoraro A, Fredberg J . Modeling Physiological Events in 2D vs. 3D Cell Culture. Physiology (Bethesda). 2017; 32(4):266-277. PMC: 5545611. DOI: 10.1152/physiol.00036.2016. View